New Discoveries in Colloidal Drug Delivery Systems

A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Nanotechnology and Applied Nanosciences".

Deadline for manuscript submissions: closed (31 January 2021) | Viewed by 262

Special Issue Editor

Head of Nano Hybrid BioInterfaces Lab (NHBIL), Department of Chemical Sciences, University of Catania, 95125 Catania, Italy
Interests: nanomaterials; biomaterials; drug delivery; stimuli-responsive materials; theranostics; surface tailoring; peptidomimetics; plasmonics; graphene oxide; hybrid biointerfaces; supported lipid bilayers; tissue repair; wound healing; cancer therapy; nanomedicine for neurodegenerative diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Nanoparticles play a key role in nanomedicine, as they can efficiently carry and deliver the therapeutic cargo, often together with imaging probes and targeting moieties, to desired sites such as cells, tissues or even a specific organ. Both experimental and theoretical research works on colloidal drug delivery systems have boomed in the last few years, with a maintained promise of revolutionary changes in the field of pharma and health sciences including drug delivery, diagnostics, and treatment (all together referred to as theranostics), point-of-care and personalized medicine. The most recent topics of colloidal drug delivery systems cover a vast research area, partially overlapping with nanotechnology, plasmonics, quantum optics, metamaterials, biomimetics, self-assembly, ‘smart’ stimuli-responsive materials, chemotherapeutic agents, biological agents, immunotherapeutic agents, etc.

The present Special Issue is devised as a collection of articles reporting both reviews of recently reported findings and new research data produced in this broad research area. We welcome articles including but not limited to: i) an updated summary of recent advances in the field of nanomedicines and colloidal-based drug delivery formulations; ii) the discovery and application of nanomaterials in improving both the efficacy of novel and old drugs (e.g., natural products) and the selective diagnosis through disease marker molecules; iii) the opportunities and challenges of nanomedicines in drug delivery from synthetic/natural sources to their clinical applications. 

Dr. Cristina Satriano
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • Nanomaterials
  • Surface functionalization
  • Biomolecule immobilization
  • Nanotechnology
  • Drug delivery
  • Imaging
  • Biosensing
  • Nanomedicine

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop